BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1182 related articles for article (PubMed ID: 10720049)

  • 1. Gender difference in insulin-like growth factor I response to growth hormone (GH) treatment in GH-deficient adults: role of sex hormone replacement.
    Span JP; Pieters GF; Sweep CG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1121-5. PubMed ID: 10720049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in rhGH-induced changes in body composition in GH-deficient adults.
    Span JP; Pieters GF; Sweep FG; Hermus AR; Smals AG
    J Clin Endocrinol Metab; 2001 Sep; 86(9):4161-5. PubMed ID: 11549643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG; Boroujerdi MA; Powrie J; Dall R; Napoli R; Ehrnborg C; Pentecost C; Cittadini A; Jørgensen JO; Sonksen PH;
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.
    Christiansen JJ; Fisker S; Gravholt CH; Bennett P; Svenstrup B; Andersen M; Feldt-Rasmussen U; Christiansen JS; Jørgensen JO
    Eur J Endocrinol; 2005 May; 152(5):719-26. PubMed ID: 15879357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    Amato G; Mazziotti G; Di Somma C; Lalli E; De Felice G; Conte M; Rotondi M; Pietrosante M; Lombardi G; Bellastella A; Carella C; Colao A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3720-5. PubMed ID: 11061530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
    Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
    J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
    Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor I levels in growth hormone-deficient adults: influence of sex steroids.
    Jørgensen JO; Christensen JJ; Krag M; Fisker S; Ovesen P; Christiansen JS
    Horm Res; 2004; 62 Suppl 1():73-6. PubMed ID: 15761236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor I levels during growth hormone (GH) replacement in GH-deficient adults: a gender difference.
    Soares DV; Conceição FL; Brasil RR; Spina LD; Lobo PM; Silva EM; Buescu A; Vaisman M
    Growth Horm IGF Res; 2004 Dec; 14(6):436-41. PubMed ID: 15519251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex steroids and the growth hormone/insulin-like growth factor-I axis in adults.
    Jørgensen JO; Christensen JJ; Vestergaard E; Fisker S; Ovesen P; Christiansen JS
    Horm Res; 2005; 64 Suppl 2():37-40. PubMed ID: 16286769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender difference in growth hormone response in adults.
    Johansson AG
    J Endocrinol Invest; 1999; 22(5 Suppl):58-60. PubMed ID: 10442572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women.
    Holloway L; Butterfield G; Hintz RL; Gesundheit N; Marcus R
    J Clin Endocrinol Metab; 1994 Aug; 79(2):470-9. PubMed ID: 7519191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency.
    Johansson AG; Engström BE; Ljunghall S; Karlsson FA; Burman P
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2002-7. PubMed ID: 10372701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human insulin-like growth factor I, recombinant human growth hormone, and sex steroids: effects on markers of bone turnover in humans.
    Mauras N; Doi SQ; Shapiro JR
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2222-6. PubMed ID: 8964855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH sensitivity of GH-deficient adults is dependent on gender but not timing of onset.
    Columb B; Smethurst LE; Mukherjee A; Jostel A; Shalet SM; Murray RD
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):281-6. PubMed ID: 18702681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group.
    Dall R; Longobardi S; Ehrnborg C; Keay N; Rosén T; Jørgensen JO; Cuneo RC; Boroujerdi MA; Cittadini A; Napoli R; Christiansen JS; Bengtsson BA; Sacca L; Baxter RC; Basset EE; Sönksen PH
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4193-200. PubMed ID: 11095453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.